Reye’s Syndrome Market is Growing Gradually at a Promising CAGR of 7.20% During Forecast 2017-2023
Market Highlights: Reye’s Syndrome is a rare disease that causes swelling of the liver and brain. Increasing prevalence of influenza and rising teenage population are the major drivers of the market growth. Moreover, increasing per capita healthcare expenditure and developing biotechnology & pharmaceutical industries within the developing economies across the world are estimated to boost the market growth during the forecasted period. However, lack of awareness, limited treatment options, and FDA approvals may restrain the market growth during the forecast period. Key Players: · General Electric Company · Siemens Healthcare Gmbh · CANON MEDICAL SYSTEMS CORPORATION · Koninklijke Philips N.V. · NeuroLogica Corp · ...